CXCL12 and esophageal cancer: Lukaszewicz-Zajac et al.87 showed that the concentrations of serum CXCL12 and CXCR4 in patients with esophageal cancers were significantly higher for CXCL12, but significantly lower for CXCR4, when compared to healthy controls.